Back to search
FDAFDA · Food and drugs·Recall number D-137-2013

Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3.

Published February 6, 2013 · Recall initiated: January 16, 2013

Summary

FDA records drug Class II recall D-137-2013, published February 6, 2013 and initiated January 16, 2013. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 11,580 bottles; Lot: Lot #: ZCMH12031, ZCMH12032, ZCMH12033, ZCMH12034, Exp 02/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide.
Lot
Lot #: ZCMH12031, ZCMH12032, ZCMH12033, ZCMH12034, Exp 02/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3. recalled?

Yes. FDA published recall D-137-2013 on February 6, 2013. Reported hazard: Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.

What should I do if I have this product?

Voluntary: Firm initiated · Letter